Certified by Founder Lodge
Bain Capital
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $12,500,000
21 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Bain Capital is one of the world’s leading alternative investment firms. More than 1,200 Bain Capital employees work together at locations in Boston, Chicago, New York, San Francisco, Palo Al
Date | Round | Raised | Participating Investors |
---|---|---|---|
November, 16 ,2022 | Series A | $12,500,000.00 |
Company | Date | Round | Raised |
---|---|---|---|
CereVasc | May, 14 ,2024 | Series B | $70,000,000 |
Atmos | November, 16 ,2022 | Series A | $12,500,000 |
Nimbus Therapeutics | September, 13 ,2022 | Unknown | $125,000,000 |
Releaf | January, 13 ,2023 | Pre Series A | $3,300,000 |
PeopleFund | January, 18 ,2023 | Series C | $20,000,000 |
SumUp | June, 23 ,2022 | Unknown | $624,000,000 |
Surf Internet | February, 13 ,2023 | Unknown | $100,000,000 |
Alloy Automation | March, 01 ,2022 | Unknown | $27,000,000 |
Overview | February, 21 ,2022 | Series A | $10,000,000 |
Swoogo | February, 08 ,2022 | Series B | $20,000,000 |
Hometap | January, 25 ,2022 | Series B | $245,000,000 |
Zero Hash | January, 12 ,2022 | Series D | $105,000,000 |
HeartFlow, Inc | April, 07 ,2023 | Series F | $215,000,000 |
Blackpoint Cyber | June, 12 ,2023 | Unknown | $190,000,000 |
LULA(US) | August, 04 ,2023 | Series B | $35,500,000 |
ADARx Pharmaceuticals Inc. | August, 10 ,2023 | Series C | $200,000,000 |
EyeBio | November, 15 ,2023 | Series A | $65,000,000 |
1440 Foods | December, 19 ,2023 | Unknown | |
Navro (formerly Paytrix) | February, 13 ,2024 | Unknown | $14,000,000 |
CereVasc | May, 14 ,2024 | Series B | $70,000,000 |
Angitia Biopharmaceuticals | December, 12 ,2024 | Series C | $120,000,000 |